diffuse large B-cell lymphoma, n = 1; follicular lymphoma, n = 1; administrational reason, n = 1). Five-year FFS probability estimates were 31% (95% CI, 26% to 37%) for R-CHOP and 31% (95% CI, 25% to ...

Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery ...

LADENBURG, Germany I May 27, 2025 I Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

A unique feature of HR is that it repairs the damage to the DNA in a highly accurate way. In eukaryotic cells (those with a ...